Fig. 2

Proposed contribution of vascular risk factors to Alzheimer’s disease. For MCI subjects, dyslipidemia may contribute Alzheimer’s disease-specific neurodegeneration, and hypertension may contribute cerebrovascular pathology. Statin therapy may be beneficial for long-term cognitive outcome